# FDA Inspection 1252426 - Mark S. LeDoux, M.D. - September 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/mark-s-ledoux-md/44a01c35-d4db-4bc1-9df7-da9492ad6ca6
Source feed: FDA_Inspections

> FDA Inspection 1252426 for Mark S. LeDoux, M.D. on September 30, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252426
- Company Name: Mark S. LeDoux, M.D.
- Inspection Date: 2024-09-30
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252426 - 2024-09-30](https://www.keypedia.com/records/fda_inspections/mark-s-ledoux-md/1fdef84e-c2f8-4703-ab49-c8f4f7cc5ca8)

Company: https://www.keypedia.com/companies/mark-s-ledoux-md/18753df1-ebd0-43eb-8bb9-83851acbe587

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c